tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
US Market
LRMR
Larimar Therapeutics
RESEARCH TOOLSreports

Larimar Therapeutics (LRMR) Stock News & Sentiment

Compare
1,106 Followers
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
Premium
Ratings
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
3d ago
LRMR
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago
LRMR
Larimar Advances Nomlabofusp Toward 2026 BLA Submission
Premium
Company Announcements
Larimar Advances Nomlabofusp Toward 2026 BLA Submission
13d ago
8K
LRMR
Larimar Therapeutics Announces Upsized Public Equity Offering
Premium
Company Announcements
Larimar Therapeutics Announces Upsized Public Equity Offering
23d ago
8K
LRMR
FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp
Premium
Company Announcements
FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp
26d ago
8K
LRMR
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know
Premium
Company Announcements
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know
2M ago
LRMR
Larimar Therapeutics executes preferred stock exchange and amendment
Premium
Company Announcements
Larimar Therapeutics executes preferred stock exchange and amendment
2M ago
8K
LRMR
More LRMR News >

LRMR News on the Web

Larimar Therapeutics price target raised to $13 from $12 at Wedbush
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS), Larimar Therapeutics (LRMR) and Eli Lilly & Co (LLY)
TipRanks News
Bullish
Citi Reaffirms Their Buy Rating on Larimar Therapeutics (LRMR)
TipRanks News
Bullish
Breakthrough Therapy Designation and Strong Cash Position Set Stage for Larimar’s Next Chapter in Rare Disease Innovation
Market Chameleon
Bullish
Larimar Therapeutics (LRMR) Q4 EPS Misses Estimates
GuruFocus News
Bearish
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
TipRanks News
Bullish
Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)
TipRanks News
Bullish
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
LRMR
Sector Average
Media Buzz
This Week8 articles
Weekly Average9.25 articles
News Sentiment
This Week86%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LRMR’s Media Buzz Sentiment?
8 articles about LRMR were published this week. In an average week, 9.25 articles are published.
    What is LRMR’s weekly average amount of articles?
    In an average week, 9.25 articles about LRMR are published.
      What is LRMR’s News Sentiment?
      86% of articles about LRMR were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        ABOSAcumen Pharmaceuticals
        KMTSKestra Medical Technologies Ltd.
        MISTMilestone Pharmaceuticals
        OVIDOvid Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week